Repression of Cyclin B1 Expression after Treatment with Adriamycin, but Not Cisplatin in Human Lung Cancer A549 Cells
- 1 January 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 280 (3), 861-867
- https://doi.org/10.1006/bbrc.2000.4231
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mechanisms of G2 Arrest in Response to Overexpression of p53Molecular Biology of the Cell, 1999
- Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cellsOncogene, 1999
- The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repressionThe EMBO Journal, 1998
- Is a p53-Regulated Inhibitor of G2/M ProgressionMolecular Cell, 1997
- Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistanceCurrent Opinion in Oncology, 1995
- A novel form of Epstein-Barr virus latency in normal B cells in vivoCell, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992
- Universal control mechanism regulating onset of M-phaseNature, 1990
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986